Literature DB >> 23588318

Transporter studies in drug development: experience to date and follow-up on decision trees from the International Transporter Consortium.

D Tweedie1, J W Polli, E Gil Berglund, S M Huang, L Zhang, A Poirier, X Chu, B Feng.   

Abstract

The International Transporter Consortium (ITC) organized a second workshop in March 2012 to expand on the themes developed during the inaugural ITC workshop held in 2008. The final session of the workshop provided perspectives from regulatory and industry-based scientists, with input from academic scientists, and focused primarily on the decision trees published from the first workshop. These decision trees have become a central part of subsequent regulatory drug-drug interaction (DDI) guidances issued over the past few years.

Mesh:

Substances:

Year:  2013        PMID: 23588318     DOI: 10.1038/clpt.2013.77

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  30 in total

1.  Downregulation of Organic Anion Transporting Polypeptide (OATP) 1B1 Transport Function by Lysosomotropic Drug Chloroquine: Implication in OATP-Mediated Drug-Drug Interactions.

Authors:  Khondoker Alam; Sonia Pahwa; Xueying Wang; Pengyue Zhang; Kai Ding; Alaa H Abuznait; Lang Li; Wei Yue
Journal:  Mol Pharm       Date:  2016-02-01       Impact factor: 4.939

Review 2.  Mass spectrometry-based targeted proteomics as a tool to elucidate the expression and function of intestinal drug transporters.

Authors:  Stefan Oswald; Christian Gröer; Marek Drozdzik; Werner Siegmund
Journal:  AAPS J       Date:  2013-08-28       Impact factor: 4.009

3.  Cellular uptake of imatinib into leukemic cells is independent of human organic cation transporter 1 (OCT1).

Authors:  Anne T Nies; Elke Schaeffeler; Heiko van der Kuip; Ingolf Cascorbi; Oliver Bruhn; Michael Kneba; Christiane Pott; Ute Hofmann; Christopher Volk; Shuiying Hu; Sharyn D Baker; Alex Sparreboom; Peter Ruth; Hermann Koepsell; Matthias Schwab
Journal:  Clin Cancer Res       Date:  2013-12-18       Impact factor: 12.531

4.  Different interaction profiles of direct-acting anti-hepatitis C virus agents with human organic anion transporting polypeptides.

Authors:  Tomomi Furihata; Shogo Matsumoto; Zhongguo Fu; Akihito Tsubota; Yuchen Sun; Sayaka Matsumoto; Kaoru Kobayashi; Kan Chiba
Journal:  Antimicrob Agents Chemother       Date:  2014-05-27       Impact factor: 5.191

5.  Drug Transporters in Xenobiotic Disposition and Pharmacokinetic Prediction.

Authors:  Qingcheng Mao; Yurong Lai; Joanne Wang
Journal:  Drug Metab Dispos       Date:  2018-05       Impact factor: 3.922

6.  Ketamine Pharmacokinetics and Pharmacodynamics Are Altered by P-Glycoprotein and Breast Cancer Resistance Protein Efflux Transporters in Mice.

Authors:  Samit Ganguly; John C Panetta; Jessica K Roberts; Erin G Schuetz
Journal:  Drug Metab Dispos       Date:  2018-04-19       Impact factor: 3.922

7.  Cadmium exposure enhances organic cation transporter 2 trafficking to the kidney membrane and exacerbates cisplatin nephrotoxicity.

Authors:  Hong Yang; Jie Tang; Dong Guo; Qingqing Zhao; Jiagen Wen; Yanjuan Zhang; Obinna N Obianom; Shiwei Zhou; Wei Zhang; Yan Shu
Journal:  Kidney Int       Date:  2019-11-26       Impact factor: 10.612

8.  Characterization of the transmembrane transport and absolute bioavailability of the HCV protease inhibitor danoprevir.

Authors:  Barbara J Brennan; Agnès Poirier; Sebastian Moreira; Peter N Morcos; Petra Goelzer; Renée Portmann; Jiney Asthappan; Christoph Funk; Patrick F Smith
Journal:  Clin Pharmacokinet       Date:  2015-05       Impact factor: 6.447

Review 9.  Key to Opening Kidney for In Vitro-In Vivo Extrapolation Entrance in Health and Disease: Part II: Mechanistic Models and In Vitro-In Vivo Extrapolation.

Authors:  Daniel Scotcher; Christopher Jones; Maria Posada; Aleksandra Galetin; Amin Rostami-Hodjegan
Journal:  AAPS J       Date:  2016-08-09       Impact factor: 4.009

Review 10.  Organic anion-transporting polypeptides.

Authors:  Bruno Stieger; Bruno Hagenbuch
Journal:  Curr Top Membr       Date:  2014       Impact factor: 3.049

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.